Showing results (491-500 of 709) with videos related to

Sort By:
Pageof 71
Gut|November 26, 2011
Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel diseaseR Kiesslich, C A Duckworth, D Moussata, et al.
Journal of Oncology|March 7, 2009
Strong expression of chemokine receptor CXCR4 by renal cell carcinoma correlates with advanced diseaseThomas C Wehler, Claudine Graf, Stefan Biesterfeld, et al.
Cell Death & Disease|July 6, 2013
Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cellsT Kohl, N Gehrke, A Schad, et al.
International Journal of Cardiology|August 6, 2018
Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial functionFrank P Schmidt, Tim Zimmermann, Till Wenz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 24, 2018
Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic InflammationYvonne Huber, Marie Boyle, Kate Hallsworth, et al.
Anti-Cancer Drugs|January 25, 2003
Safety and efficacy of outpatient treatment with CPT-11 plus bolus folinic acid/5-fluorouracil as first-line chemotherapy for metastatic colorectal cancerMarkus Moehler, Tanja Hoffmann, Christine Zanke, et al.
International Immunology|May 15, 2007
Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cellsSusetta Finotto, Tatjana Eigenbrod, Roman Karwot, et al.
The Journal of General Virology|September 28, 2004
Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infectionSoheila Tavakoli, Wibke Schwerin, Andreas Rohwer, et al.
Cancers|June 4, 2020
BAX Redistribution Induces Apoptosis Resistance and Selective Stress Sensitivity in Human HCCKathrin Funk, Carolin Czauderna, Ramona Klesse, et al.
Liver Cancer|December 17, 2024
Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma with Main Trunk and/or Contralateral Portal Vein Invasion in IMbrave150Richard S Finn, Peter R Galle, Michel Ducreux, et al.
Pageof 71